Study Reveals Parents Are Delaying Introduction of Allergic Foods Despite Health Guidelines

Recent research shows many parents are delaying the introduction of allergy-causing foods to infants, increasing the risk of food allergies despite public health guidelines recommending early exposure.
A recent study published in the European Journal of Clinical Nutrition highlights a concerning trend among parents who are not following recommended guidelines for introducing highly allergenic foods to infants. The research found that many parents delay giving children foods like eggs and nuts until after 12 months, contrary to advice from health authorities such as the NHS, which recommends starting these foods around six months. The delay may increase the risk of developing food allergies, as early exposure has been linked to allergy prevention. Led by Dr. Suzannah Helps from the University of Portsmouth, the study sampled 390 families, tracking their feeding practices from pregnancy through toddlers aged 24 months. The findings revealed that families with a history of allergies were more likely to avoid allergenic foods, which paradoxically raises the chances of their children developing allergies. Although most infants began eating allergenic foods between 6 and 9 months, a significant number—about 20%—had yet to try eggs by 12 months, and one-third had not tried nuts, showing a gap between professional guidance and real-world practices. Historical advice to avoid allergenic foods may have inadvertently contributed to the allergy epidemic. This new research echoes findings from studies like LEAP and EAT, emphasizing the importance of early exposure for allergy prevention. Experts stress the need to better educate parents and caregivers on current guidelines to help curb the rise of food allergies in children. Addressing this gap can promote healthier dietary habits and potentially reduce allergy cases in future generations.
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
New Insights into Tamoxifen's Side Effects: Elevated Uterine Cancer Risk Explained
Recent research uncovers how tamoxifen activates the PI3K pathway, increasing the risk of secondary uterine tumors, despite its benefits in breast cancer treatment. Discover the molecular insights behind this paradoxical effect.
Innovative Shorter MRI Scan Could Transform Prostate Cancer Diagnosis for Men Globally
A new two-part MRI scan offers a faster, cheaper, and equally effective method for diagnosing prostate cancer, with the potential to improve access and early detection worldwide.
New Vaccination Strategy Shows Promise in Preventing Recurrence of Colorectal and Pancreatic Cancers
A novel off-the-shelf vaccine shows promise in preventing recurrence of colorectal and pancreatic cancers with KRAS mutations, offering hope for improved cancer immunotherapy outcomes.
Innovative Vaginal Speculum Design Aims to Reduce Fear and Discomfort During Gynecological Exams
A team of researchers has redesigned the traditional vaginal speculum to make gynecological exams more comfortable, less intimidating, and less painful, potentially improving women's healthcare experiences.



